EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Epilepsy with faint capillary malformation or reticulated telangiectasia associated with mosaic AKT3 pathogenic variants

Martina De Bortoli iD, Marta Ivars iD, Nicole Revencu iD, Marie-Cécile Nassogne iD, Cinzia Lavarino iD, Sonia Paco iD, Martin Lammens iD, Anne Renders iD, Dana Dumitriu iD, Raphaël Helaers iD, Laurence M Boon iD, Eulalia Baselga iD und 1 weitere

American Journal of Medical Genetics Part A · 2024

DOI: 10.1002/ajmg.a.63551 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Martina De Bortoli und 12 weiteren Autor:innen. Beteiligte Einrichtung: Human Molecular Genetics, de Duve Institute, UCLouvain, Brussels, Belgium. Hauptthemen laut MEDLINE: Capillaries, Epilepsy, Proto-Oncogene Proteins c-akt, Telangiectasis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Sinergia Project nro, European Union's Horizon 2020 Research and Innovation Program (Theralymph).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Capillary malformations (CMs) are the most common type of vascular anomalies, affecting around 0.3% of newborns. They are usually caused by somatic pathogenic variants in GNAQ or GNA11 . PIK3CA and PIK3R1 , part of the phosphoinositide 3‐kinase–protein kinase B–mammalian target of rapamycin pathway, are mutated in fainter CMs such as diffuse CM with overgrowth and megalencephaly CM. In this study, we present two young patients with a CM‐like phenotype associated with cerebral anomalies and severe epilepsy. Pathogenic variants in PIK3CA and PIK3R1 , as well as GNAQ and GNA11 , were absent in affected cutaneous tissue biopsies. Instead, we identified two somatic pathogenic variants in the AKT3 gene. Subsequent analysis of the DNA obtained from surgically resected brain tissue of one of the two patients confirmed the presence of the AKT3 variant. Focal cortical dysplasia was also detected in this patient. Genetic analysis thus facilitated workup to reach a precise diagnosis for these patients, associating the vascular anomaly with the neurological symptoms. This study underscores the importance of searching for additional signs and symptoms to guide the diagnostic workup, especially in cases with atypical vascular malformations. In addition, it strongly emphasizes the significance of genotype–phenotype correlation studies in guiding clinicians' informed decision‐making regarding patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CapillariesEpilepsyProto-Oncogene Proteins c-aktTelangiectasisVascular MalformationsFemaleHumansInfant, NewbornMaleGenetic Association StudiesGenetic Predisposition to DiseaseMosaicismMutationPhenotypeAdolescent

Stichwörter der Autor:innen

PI3K signalingdiagnosisepilepsyfocal cortical dysplasiageneticsomaticvascular malformation

Substanzen

AKT3 protein, humanProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Human Molecular Genetics, de Duve Institute, UCLouvain, Brussels, Belgium.
  • Department of Dermatology, VASCERN VASCA European Reference Center, Hospital Sant Joan de Deu, Barcelona, Spain.
  • Center for Human Genetics, VASCERN VASCA European Reference Center, Cliniques Universitaires Saint Luc, UCLouvain, Brussels, Belgium.
  • Pediatric Neurology Unit, VASCERN VASCA European Reference Center, Cliniques Universitaires Saint Luc, UCLouvain, Brussels, Belgium.
  • Laboratory of Molecular Oncology, VASCERN VASCA European Reference Center, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Department of Pathology, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.

ORCID-Profile: Martina De Bortoli, Marta Ivars, Nicole Revencu, Marie-Cécile Nassogne, Cinzia Lavarino, Sonia Paco, Martin Lammens, Anne Renders, Dana Dumitriu, Raphaël Helaers, Laurence M Boon, Eulalia Baselga, Miikka Vikkula

Förderung

  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Sinergia Project nro
  • European Union's Horizon 2020 Research and Innovation Program (Theralymph)
  • Leducq Foundation Networks of Excellence Program grant 'ReVAMP' (LFCR grant)
  • MSCA-ITN network V.A. Cure
  • FRFS-WELBIO Strategic Research Program
  • Fund Generet managed by King Baudouin Foundation
  • Fonds De La Recherche Scientifique-FNRS

Zitieren

APA

De Bortoli, M., Ivars, M., Revencu, N., Nassogne, M. C., Lavarino, C., Paco, S., Lammens, M., Renders, A., Dumitriu, D., Helaers, R., Boon, L. M., Baselga, E., & Vikkula, M. (2024). Epilepsy with faint capillary malformation or reticulated telangiectasia associated with mosaic AKT3 pathogenic variants. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63551

Vancouver

De Bortoli M, Ivars M, Revencu N, Nassogne MC, Lavarino C, Paco S, et al. Epilepsy with faint capillary malformation or reticulated telangiectasia associated with mosaic AKT3 pathogenic variants. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63551

BibTeX
@article{DeBortoli2024,
  author = {De Bortoli, Martina and Ivars, Marta and Revencu, Nicole and Nassogne, Marie-Cécile and Lavarino, Cinzia and Paco, Sonia and Lammens, Martin and Renders, Anne and Dumitriu, Dana and Helaers, Raphaël and Boon, Laurence M and Baselga, Eulalia and Vikkula, Miikka},
  title = {Epilepsy with faint capillary malformation or reticulated telangiectasia associated with mosaic AKT3 pathogenic variants},
  journal = {American Journal of Medical Genetics Part A},
  year = {2024},
  doi = {10.1002/ajmg.a.63551}
}
Kostenlos starten →